Author: Caspian Sterling

Never double up on missed medication doses-it can be dangerous. Learn the safe, science-backed rules for what to do when you forget a pill, based on drug type, timing, and risk level.

Uremic symptoms like nausea and severe itching signal kidney failure. Learn when these signs mean it's time to start dialysis, how to manage them, and why waiting too long can be dangerous.

Magnesium supplements can block the absorption of osteoporosis medications like Fosamax. Learn the exact 2-hour timing rule to protect your bone density and avoid treatment failure.

Chronic GERD is the top risk factor for esophageal cancer. Learn the red flags - like trouble swallowing and unexplained weight loss - and what steps you can take to lower your risk if you've had acid reflux for five years or more.

Patent Term Restoration lets drugmakers recover time lost during FDA approval, extending market exclusivity by up to five years. Learn how it works, who qualifies, and why it's both essential and controversial.

Generic drugs save Americans billions each year-90% of prescriptions are generic, but they cost only 12% of what brand drugs do. Learn the real numbers, how they work, and how to save on your prescriptions today.

Healthcare provider attitudes are shifting fast by 2026. Patients bring wearable data, AI supports diagnosis, and flexible teams replace rigid schedules. Learn how providers are adapting to technology, workforce changes, and the new patient partnership.

States are using MAC lists, anti-price-gouging laws, and PBM transparency to control Medicaid generic drug costs. With 84.7% of prescriptions being generics, these policies save billions-but must balance savings with drug availability.

Generic drugs are just as safe as brand-name ones - but sometimes, inactive ingredients or patient expectations cause unexpected reactions. Learn what really causes drug interaction issues with generics and how to stay safe.

For people with chronic spontaneous urticaria who don't respond to antihistamines, second-line treatments like omalizumab, remibrutinib, and dupilumab offer real hope. Learn what works, what's new, and how to find the right option.